|
|
|
|
|
|
Found 57 studies with search of: | "Calcitriol" |
Hide studies that are not seeking new volunteers.
|
|
1 | Active, not recruiting | Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | ||||
Conditions: | Androgen Independent Prostate Cancer (AIPC); Non Small Cell Lung Cancer (NSCLC) | |||||
Intervention: | Drug: DN-101 (calcitriol) - Drug | |||||
2 | Not yet recruiting | Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects | ||||
Conditions: | Secondary Hyperparathyroidism; Dialysis | |||||
Interventions: | Drug: Calcitriol; Drug: Paricalcitol | |||||
3 | Recruiting | Vitamin D and Coronary Calcification Study | ||||
Conditions: | Chronic Kidney Disease; Vitamin D; Coronary Calcification; Bone Metabolism | |||||
Interventions: | Drug: Calcitriol (Rocaltrol®); Drug: Paricalcitol | |||||
4 | Recruiting | Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis | ||||
Condition: | Psoriasis | |||||
Interventions: | Drug: clobetasol propionate spray 0.05%; Drug: calcitriol ointment | |||||
5 | Active, not recruiting | Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) | ||||
Condition: | Myelodysplastic Syndrome | |||||
Intervention: | Drug: DN-101 (calcitriol) | |||||
6 | Recruiting | A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis | ||||
Condition: | Chronic Plaque Psoriasis | |||||
Intervention: | Drug: Calcitriol | |||||
7 | Terminated | DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: docetaxel | |||||
8 | Suspended | A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer | ||||
Condition: | Pancreatic Cancer | |||||
Interventions: | Drug: placebo + gemcitabine + erlotinib; Drug: Placebo + gemcitabine; Drug: calcitriol + gemcitabine; Drug: calcitriol + gemcitabine + erlotinib | |||||
9 | Recruiting | The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria | ||||
Conditions: | Systemic Lupus Erythematosus; Nephritis; Proteinuria | |||||
Interventions: | Drug: Calcitriol; Drug: Multivitamin | |||||
10 | Completed | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | ||||
Condition: | Carcinoma, Non-Small-Cell Lung | |||||
Intervention: | Drug: calcitriol + docetaxel | |||||
11 | Active, not recruiting | Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: mitoxantrone hydrochloride; Drug: prednisone | |||||
12 | Recruiting | Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia | ||||
Condition: | Hypocalcemia | |||||
Interventions: | Drug: Teriparatide; Drug: Calcium; Drug: Calcitriol | |||||
13 | Recruiting | Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes | ||||
Condition: | Myelodysplastic Syndromes | |||||
Interventions: | Drug: Calcitriol; Drug: Dexamethasone | |||||
14 | Active, not recruiting | Calcitriol in the Treatment of IgA Nephropathy | ||||
Condition: | IGA Nephropathy | |||||
Intervention: | Drug: Calcitriol | |||||
15 | Active, not recruiting | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone | |||||
16 | Active, not recruiting | Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia | ||||
Conditions: | Precancerous/Nonmalignant Condition; Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Procedure: observation | |||||
17 | Recruiting | Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma | ||||
Conditions: | Intraocular Melanoma; Melanoma (Skin) | |||||
Interventions: | Drug: calcitriol; Drug: temozolomide | |||||
18 | Active, not recruiting | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: zoledronic acid | |||||
19 | Completed | Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | ||||
Condition: | Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone; Drug: ketoconazole | |||||
20 | Recruiting | Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer | ||||
Conditions: | Lung Cancer; Precancerous/Nonmalignant Condition; Tobacco Use Disorder | |||||
Interventions: | Drug: calcitriol; Procedure: laboratory biomarker analysis; Procedure: pharmacological study | |||||
21 | Active, not recruiting | Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer | ||||
Condition: | Prostate Cancer | |||||
Intervention: | Drug: calcitriol | |||||
22 | Active, not recruiting | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | ||||
Condition: | Pancreatic Cancer | |||||
Interventions: | Drug: calcitriol; Drug: docetaxel | |||||
23 | Completed | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | ||||
Condition: | Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: calcitriol; Drug: paclitaxel | |||||
24 | Recruiting | Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: ketoconazole; Drug: therapeutic hydrocortisone | |||||
25 | Active, not recruiting | Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | ||||
Conditions: | Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: calcitriol; Drug: carboplatin | |||||
26 | Active, not recruiting | Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors | ||||
Condition: | Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone; Drug: gefitinib | |||||
27 | Active, not recruiting | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone; Procedure: laboratory biomarker analysis; Procedure: protein expression analysis | |||||
28 | Recruiting | Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone; Procedure: observation | |||||
29 | Active, not recruiting | Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: dexamethasone | |||||
30 | Recruiting | Calcitriol, Cisplatin, and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||||
Condition: | Lung Cancer | |||||
Interventions: | Drug: calcitriol; Drug: cisplatin; Drug: docetaxel; Procedure: laboratory biomarker analysis; Procedure: pharmacological study; Procedure: polymorphism analysis | |||||
31 | Completed | Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions | ||||
Conditions: | Secondary Hyperparathyroidism; Hypocalcemia | |||||
Intervention: | Drug: Calcitriol | |||||
32 | Active, not recruiting | Effects of Vitamin D on Renin Expression in Hypertensive Patients | ||||
Conditions: | Hypertension; Vitamin D Deficiency | |||||
Intervention: | Drug: calcitriol | |||||
33 | Active, not recruiting | Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | ||||
Condition: | Prostatic Neoplasms | |||||
Intervention: | Drug: Vitamin D (Calcitriol) | |||||
34 | Active, not recruiting | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: docetaxel | |||||
35 | Completed | Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis | ||||
Condition: | Psoriasis | |||||
Intervention: | Drug: calcitriol | |||||
36 | Completed | Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease | ||||
Condition: | Crohn's Disease | |||||
Intervention: | Drug: Delayed Release 6MP or Calcitriol vs. Purinethol | |||||
37 | Completed | A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies | ||||
Condition: | Neoplasms | |||||
Intervention: | Drug: DN-101 | |||||
38 | Active, not recruiting | Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | ||||
Condition: | Prostate Cancer | |||||
Interventions: | Drug: calcitriol; Drug: carboplatin | |||||
39 | Completed | Study of Topical Calcitriol in Children With Psoriasis | ||||
Condition: | Psoriasis | |||||
Intervention: | Drug: calcitriol | |||||
40 | Completed | Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium | ||||
Conditions: | Secondary Hyperparathyroidism; Chronic Kidney Disease | |||||
Interventions: | Drug: Zemplar; Procedure: 42 Ca carbonate absorption via single tracer method; Drug: Calcijex | |||||
41 | Terminated | Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis | ||||
Condition: | End-Stage Kidney Disease | |||||
Interventions: | Drug: Zemplar (paricalcitol injection); Drug: Calcijex | |||||
42 | Active, not recruiting | Effects of Calcitriol Versus PTH Replacement Therapy in Patients With Hypoparathyroidism | ||||
Condition: | Hypoparathyroidism | |||||
Intervention: | Drug: Synthetic Human PTH 1-34 | |||||
43 | Not yet recruiting | Vitamin D for the Treatment of Severe Asthma | ||||
Condition: | Asthma | |||||
Interventions: | Drug: Placebo; Drug: Calcitriol | |||||
44 | Suspended | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | ||||
Condition: | Prostatic Neoplasms | |||||
Interventions: | Drug: DN-101; Drug: Naproxen (Naprosyn) | |||||
45 | Completed | Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis | ||||
Condition: | Osteopetrosis | |||||
Interventions: | Drug: calcitriol; Drug: interferon gamma | |||||
46 | Recruiting | Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | ||||
Conditions: | Rheumatoid Arthritis; Crohn's Disease | |||||
Intervention: | Drug: calcitriol | |||||
47 | Completed | Osteoporosis Prevention After Heart Transplant | ||||
Conditions: | Osteoporosis; Cardiac Transplantation | |||||
Interventions: | Drug: Alendronate; Drug: Calcitriol | |||||
48 | Completed | Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis | ||||
Conditions: | Renal Osteodystrophy; End Stage Renal Disease | |||||
Interventions: | Drug: calcitriol; Drug: growth hormone | |||||
49 | Completed | Regulation of Bone Formation in Renal Osteodystrophy | ||||
Conditions: | Secondary Hyperparathyroidism; Renal Osteodystrophy | |||||
Interventions: | Drug: 1 alpha D2; Drug: 1,25 dihydroxy vitamin D3; Drug: Sevelamer HCl; Drug: Calcium Carbonate | |||||
50 | Recruiting | Investigation of Antipsoriatic Effects of UVB-Induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol | ||||
Condition: | Psoriasis Vulgaris | |||||
Interventions: | Drug: Ketokonazol 2% cream; Radiation: UVB-radiation 311nm | |||||
Studies Shown (1-50) | Next (51-57) |